Improved liver health: Semaglutide may help reduce the risk of non-alcoholic fatty liver disease (NAFLD), which is more common in people with obesity and PCOS
Research published in major obesity journals demonstrates that approximately 50% of weight lost on GLP-1 therapy returns within 12 months of discontinuation, with some patients gaining back even more due to metabolic adaptation
Recent discoveries have revealed novel regulation of the Hippo pathway, with GLP-1 promoting the nuclear translocation and activation of YAP/TAZ, leading to the activation of regenerative gene programs [29]
Elevated creatinine levels are also observed with high-protein diets
So as we have less of that around perimenopause, menopause, we're going to have more sleep disruption because we're not as effective at keeping our throat open
We need to know your blood pressure because it's not appropriate for us to give you a prescription if your blood pressure is below a certain level or above a certain level